e-therapeutics (LON:ETX) Share Price Crosses Below 200 Day Moving Average of $11.94

e-therapeutics plc (LON:ETX)’s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 11.94 ($0.15) and traded as low as GBX 9.88 ($0.12). e-therapeutics shares last traded at GBX 10.20 ($0.13), with a volume of 4,338,035 shares changing hands.

e-therapeutics Price Performance

The company has a fifty day moving average price of GBX 12.72 and a two-hundred day moving average price of GBX 11.91. The company has a current ratio of 22.20, a quick ratio of 20.13 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of £58.58 million, a PE ratio of -501.25 and a beta of 0.48.

About e-therapeutics

e-therapeutics plc engages in drug discovery research activities in the United Kingdom. It offers HepNet, a proprietary, hepatocyte-specific, and computational biology platform that addresses key limitations of the biopharmaceutical industry, including extracting value from big data, addressing complex diseases, and improving translatability in research and development; and GalOmic, a RNA interference (RNAi) chemistry platform, which enables the generation of GalNAc-conjugated short interfering RNA drug candidates for hepatocyte-specific gene silencing through RNAi of any target gene identified by HepNet.